AXGN Axogen, Inc.

56.35USD-1.05%Mkt Cap: 3.37B USDP/E: —

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a pro…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap3.37B USD
Enterprise Value3.07B USD
Revenue (TTM)266.93M USD
Gross Profit167.35M USD
Net Income (TTM)-15.70M USD
Revenue/Share5.16 USD
Last Price56.35 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees622
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)79.88
PEG99.04
EV/EBITDA-441.41
EV/Revenue11.51
P/S12.61
P/B6.78
EPS (TTM)-0.63 USD
EPS (Forward)0.71 USD
52W Range
23.0091% of range59.72
52W High59.72 USD
52W Low23.00 USD
Profitability
Gross Margin74.31%
Oper. Margin-5.17%
EBITDA Margin-2.61%
Profit Margin-6.97%
ROE-12.19%
ROA-7.08%
ROIC-4.00%
ROCE-3.96%
Growth
Revenue Growth26.20%
Earnings Growth300.00%
Cash Flow & Leverage
Operating CF812.00K USD
CapEx (TTM)5.59M USD
FCF Margin11.17%
FCF Yield0.89%
Net Debt-328.60M USD
Net Debt/EBITDA47.20
Net Debt/FCF-11.02
Balance Sheet
Debt/Equity0.52
Current Ratio12.02
Quick Ratio10.48
Book Value/Sh8.31 USD
Cash/Share5.83 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJan 27, 2010
Pay DateFeb 12, 2010
Splits
Last Split105:100
Split DateJul 11, 1994
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)59.27 USD
Upside (mean)+5.2%
Target Range56.00 USD – 65.00 USD
56.00+5.2% to mean65.00
# Analysts11
Ownership
Shares Out.59.73M
Float54.61M
Insiders1.94%
Institutions104.14%
Short Interest
Short Ratio3.6d
Short % Float13.32%
Short % Out.11.71%
Shares Short6.99M
Short (prev mo.)4.70M
Technical
SMA 5043.41 (+29.8%)
SMA 20040.63 (+38.7%)
Beta1.15
S&P 52W Chg12.08%
Avg Vol (30d)1.83M
Avg Vol (10d)1.83M
Technical Indicators
RSI (14)68.5
MACD4.0609
MACD Signal3.5823
MACD Hist.+0.4785
BB Upper62.76 USD
BB Middle50.34 USD
BB Lower37.92 USD
BB Width49.33%
ATR (14)2.735 USD
Vol Ratio (20d)0.49x

About Axogen (NASDAQ: AXGN)

›

Axogen (NASDAQ: AXGN) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 622 employees.

The shares were at 56.35 USD on 19 November 2026, up 134.9% over 52 weeks. Its 52-week range is 23.00 USD to 59.72 USD: the price is 5.6% below the high and 145.0% above the low.

Its market capitalisation is 3.37B USD.

Axogen reports return on equity of -12.2%, an operating margin of -5.2% and revenue up 26.2% year over year.

It holds more cash than debt, a net cash position of 328.60M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 11 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 59.27 USD is 5.2% above the current price. The next earnings report is expected on 23 February 2027.